AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32616559 — intervention group
Group type: EXPERIMENTAL
Intervention: RFM-visible
Number of subjects: 14
Study 32616559 — intervention group
Group type: COMPARATOR
Intervention: RFM-masked
Number of subjects: 14
Study 35180902 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye relaxation system with far-infrared nanomaterials
Number of subjects: 120
Study 35180902 — intervention group
Group type: COMPARATOR
Intervention: Visual-motor training
Number of subjects: 120
Study 33900515 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (400 mg every day)
Number of subjects: 90
Study 34874478 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-NODAGA-LM3
Number of subjects: 40
Study 34874478 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-DOTA-LM3
Number of subjects: 40
Study 34874478 — intervention group
Group type: COMPARATOR
Intervention: 68Ga-DOTATATE
Number of subjects: 40
Study 32145279 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV) exercise
Number of subjects: 117
Study 32145279 — intervention group
Group type: COMPARATOR
Intervention: Simulated WBV (SIM) exercise
Number of subjects: 117
Study 32145279 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study 36127863 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention and Relationship Education's (PREP) Within My Reach (WMR) intervention
Number of subjects: 1129
Study 36127863 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 1129
Study 32879450 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshly prepared pasta meal
Number of subjects: 10
Study 32879450 — intervention group
Group type: COMPARATOR
Intervention: Chilled pasta meal
Number of subjects: 10
Study 32879450 — intervention group
Group type: COMPARATOR
Intervention: Chilled/reheated pasta meal
Number of subjects: 10
Study 32879450 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 10
Study 32824190 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-assisted intervention (health education sessions, regular weight monitoring, feedback via smartphone application)
Number of subjects: 573
Study 32824190 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual practice)
Number of subjects: 573
Study 32824190 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-assisted intervention
Number of subjects: 573
Study 36235575 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation 2000 IU/day
Number of subjects: 70
Study 36235575 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation 4000 IU/day
Number of subjects: 70
Study 36235575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 33359750 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (yogasanas with static loosening exercises for 50 min, 5 days a week for 3 months)
Number of subjects: 300
Study 33359750 — intervention group
Group type: COMPARATOR
Intervention: Non-Yoga group (simple physical exercises)
Number of subjects: 300
Study 32348531 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal corticosteroid implants
Number of subjects: 0
Study 32348531 — intervention group
Group type: COMPARATOR
Intervention: Anti-VEGF agents
Number of subjects: 0
Study 36011613 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic dynamic sling
Number of subjects: 41
Study 36011613 — intervention group
Group type: COMPARATOR
Intervention: Bobath sling
Number of subjects: 41
Study 32344201 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous postoperative pericardial flushing (CPPF) method
Number of subjects: 170
Study 32344201 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 170
Study 33998541 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 18
Study 33998541 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 18
Study 32747361 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose afabicin (i.v. 80 mg, followed by oral 120 mg, BID)
Number of subjects: 0
Study 32747361 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose afabicin (i.v. 160 mg, followed by oral 240 mg, BID)
Number of subjects: 0
Study 32747361 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin/linezolid (i.v. vancomycin 1 g or 15 mg/kg, followed by oral linezolid 600 mg, BID)
Number of subjects: 0
Study 35941796 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 0
Study 34444281 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-active release therapy (mART)
Number of subjects: 38
Study 34444281 — intervention group
Group type: COMPARATOR
Intervention: Control group (hot pack and educational briefing)
Number of subjects: 38
Study 32356413 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-hour fasting
Number of subjects: 160
Study 32356413 — intervention group
Group type: COMPARATOR
Intervention: expedited oral feeding
Number of subjects: 160
Study 34004046 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood obesity (1-SD increase in BMI)
Number of subjects: 0
Study 34004046 — intervention group
Group type: COMPARATOR
Intervention: Genetic predisposition to childhood obesity
Number of subjects: 0
Study 32473365 — intervention group
Group type: EXPERIMENTAL
Intervention: Mangifera indica leaf extract (MLE), 500 mg orally
Number of subjects: 16
Study 32473365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 32473365 — intervention group
Group type: EXPERIMENTAL
Intervention: Mangifera indica leaf extract (MLE)
Number of subjects: 16
Study 32473365 — intervention group
Group type: COMPARATOR
Intervention: Caffeine
Number of subjects: 16
Study 35643952 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day sequential treatment for H. pylori eradication
Number of subjects: 28
Study 35643952 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific treatment mentioned)
Number of subjects: 28
Study 35049196 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscera massage + lifestyle intervention
Number of subjects: 80
Study 35049196 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention only
Number of subjects: 80
Study 32133606 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 751
Study 32133606 — intervention group
Group type: COMPARATOR
Intervention: Treatment of physician's choice (TPC)
Number of subjects: 751
Study 35754258 — intervention group
Group type: EXPERIMENTAL
Intervention: FES + GT
Number of subjects: 34
Study 35754258 — intervention group
Group type: COMPARATOR
Intervention: PLBO + GT
Number of subjects: 34
Study 34107553 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical perforations of the recipient bed
Number of subjects: 26
Study 34107553 — intervention group
Group type: COMPARATOR
Intervention: Control group (intact cortex)
Number of subjects: 26
Study 32646701 — intervention group
Group type: COMPARATOR
Intervention: White patients (reference group)
Number of subjects: 22638
Study 32646701 — intervention group
Group type: EXPERIMENTAL
Intervention: Black patients
Number of subjects: 22638
Study 32646701 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian patients
Number of subjects: 22638
Study 32646701 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic patients
Number of subjects: 22638
Study 32646701 — intervention group
Group type: EXPERIMENTAL
Intervention: Black race
Number of subjects: 22638
Study 33226202 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (90 kVp, reduced radiation and standard CM dose)
Number of subjects: 126
Study 33226202 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol C (90 kVp, standard radiation and reduced CM dose)
Number of subjects: 126
Study 33226202 — intervention group
Group type: COMPARATOR
Intervention: Protocols B and C
Number of subjects: 126
Study 33226202 — intervention group
Group type: COMPARATOR
Intervention: Protocols A, B, and C
Number of subjects: 126
Study 35309891 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tsDCS and textured insoles
Number of subjects: 23
Study 35309891 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tsDCS and smooth insoles
Number of subjects: 23
Study 35309891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham tsDCS and textured insoles
Number of subjects: 23
Study 35309891 — intervention group
Group type: COMPARATOR
Intervention: Sham tsDCS and smooth insoles
Number of subjects: 23
Study 33670235 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 308
Study 33670235 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary Assessment and Treatment including ACT (TEAM)
Number of subjects: 308
Study 33670235 — intervention group
Group type: COMPARATOR
Intervention: Control (Treatment as Usual)
Number of subjects: 308
Study 35934770 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching arm (BI 695501 and adalimumab RP)
Number of subjects: 238
Study 35934770 — intervention group
Group type: COMPARATOR
Intervention: Continuous arm (adalimumab RP)
Number of subjects: 238
Study 33354799 — intervention group
Group type: EXPERIMENTAL
Intervention: Total-etch/conventional composite (TC)
Number of subjects: 60
Study 33354799 — intervention group
Group type: EXPERIMENTAL
Intervention: Total-etch/bulk-fill composite (TB)
Number of subjects: 60
Study 33354799 — intervention group
Group type: COMPARATOR
Intervention: Self-etch/conventional composite (SC)
Number of subjects: 60
Study 33354799 — intervention group
Group type: COMPARATOR
Intervention: Self-etch/bulk-fill composite (SB)
Number of subjects: 60
Study 33354799 — intervention group
Group type: COMPARATOR
Intervention: Conventional composite
Number of subjects: 60
Study 33354799 — intervention group
Group type: COMPARATOR
Intervention: Bulk-fill composite
Number of subjects: 60
Study 36432436 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical group (MHD plus nutraceutical supplementation: Vitamin E, L-glutathione, silymarin, and hepato-active compounds)
Number of subjects: 68
Study 36432436 — intervention group
Group type: COMPARATOR
Intervention: Control group (Mediterranean hypocaloric diet only)
Number of subjects: 68
Study 34817396 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (2 mg intravenously)
Number of subjects: 100
Study 34817396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32861773 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND (Supporting Teens' Autonomy Daily)
Number of subjects: 278
Study 32861773 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 278
Study 36438978 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS-guided TIVA (group B)
Number of subjects: 0
Study 36438978 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical practice (group S)
Number of subjects: 0
Study 33309893 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine hydrochloride
Number of subjects: 84
Study 33309893 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl solution (placebo)
Number of subjects: 84
Study 36284288 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (0.2 mg IV)
Number of subjects: 258
Study 36284288 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 258
Study 36284288 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 258
Study 36284288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study 33765358 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-06410293 (adalimumab-afzb) administered by prefilled syringe (PFS)
Number of subjects: 164
Study 33765358 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-06410293 (adalimumab-afzb) administered by prefilled pen (PFP)
Number of subjects: 164
Study 33765358 — intervention group
Group type: COMPARATOR
Intervention: Both PFS and PFP
Number of subjects: 164
Study 33823419 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based exercise
Number of subjects: 0
Study 33823419 — intervention group
Group type: COMPARATOR
Intervention: Routine activities
Number of subjects: 0
Study 33075192 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual physiotherapy for pelvic floor muscle training
Number of subjects: 362
Study 33075192 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based physiotherapy for pelvic floor muscle training
Number of subjects: 362
Study 35965182 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mA anodal 20-minute tDCS over the left primary motor cortex, administered three consecutive sessions every month for five months
Number of subjects: 23
Study 35965182 — intervention group
Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 23
Study 33852738 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphala toothwipes
Number of subjects: 27
Study 33852738 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothwipes
Number of subjects: 27
Study 32044089 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic culture
Number of subjects: 100
Study 32044089 — intervention group
Group type: COMPARATOR
Intervention: Static culture
Number of subjects: 100
Study 33401946 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (rtCGM)
Number of subjects: 75
Study 33401946 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexcom G6 (rtCGM with predictive alerts)
Number of subjects: 75
Study 33401946 — intervention group
Group type: COMPARATOR
Intervention: Dexcom G5 (rtCGM without predictive alerts)
Number of subjects: 75
Study 32572439 — intervention group
Group type: EXPERIMENTAL
Intervention: AcceleDent® (vibratory device)
Number of subjects: 40
Study 32572439 — intervention group
Group type: COMPARATOR
Intervention: Fixed appliance only
Number of subjects: 40
Study 34414491 — intervention group
Group type: EXPERIMENTAL
Intervention: Locking plate fixation with elimination of irreducible intercalary fragments (Group 1)
Number of subjects: 65
Study 34414491 — intervention group
Group type: COMPARATOR
Intervention: Locking plate fixation for noncomminuted fractures (Group 2)
Number of subjects: 65
Study 34414491 — intervention group
Group type: EXPERIMENTAL
Intervention: Locking plate fixation (Group 1)
Number of subjects: 65
Study 34414491 — intervention group
Group type: COMPARATOR
Intervention: Locking plate fixation (Group 2)
Number of subjects: 65
Study 34801802 — intervention group
Group type: EXPERIMENTAL
Intervention: Proficiency-based training
Number of subjects: 9
Study 34801802 — intervention group
Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 9
Study 34801802 — intervention group
Group type: EXPERIMENTAL
Intervention: Both training groups
Number of subjects: 9
Study 35028171 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfrey ointment
Number of subjects: 80
Study 35028171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 36036296 — intervention group
Group type: EXPERIMENTAL
Intervention: External attentional focus instructions
Number of subjects: 40
Study 36036296 — intervention group
Group type: COMPARATOR
Intervention: Internal attentional focus instructions
Number of subjects: 40
Study 36036296 — intervention group
Group type: EXPERIMENTAL
Intervention: Supra-postural tasks
Number of subjects: 40
Study 36036296 — intervention group
Group type: COMPARATOR
Intervention: Postural tasks
Number of subjects: 40
Study 33022105 — intervention group
Group type: EXPERIMENTAL
Intervention: K-well-nourished E. urophylla × camaldulensis clone under severe water deficit
Number of subjects: 2
Study 33022105 — intervention group
Group type: COMPARATOR
Intervention: E. urophylla with severe water deficit
Number of subjects: 2
Study 32915777 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined increase in HDL levels
Number of subjects: 215551
Study 32915777 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable MR analysis adjusting for LDL, TGs, BMI, and age at menarche
Number of subjects: 215551
Study 32915777 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants independent of leading association at core HDL pathway genes
Number of subjects: 215551
Study 35180097 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency pulsed electromagnetic fields and TCM kneading manipulation
Number of subjects: 80
Study 35180097 — intervention group
Group type: COMPARATOR
Intervention: Oral Aceclofenac sustained-release tablets, calcium carbonate and vitamin D3 tablets
Number of subjects: 80
Study 32800469 — intervention group
Group type: EXPERIMENTAL
Intervention: Double balloon catheter
Number of subjects: 21
Study 32800469 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin pessary
Number of subjects: 21
Study 34391293 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 40
Study 34391293 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 40
Study 34391293 — intervention group
Group type: EXPERIMENTAL
Intervention: Between group comparison
Number of subjects: 40
Study 32040183 — intervention group
Group type: EXPERIMENTAL
Intervention: List experiment method (treatment group)
Number of subjects: 786
Study 32040183 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-sensitive items)
Number of subjects: 786
Study 32040183 — intervention group
Group type: EXPERIMENTAL
Intervention: Registered FSWs
Number of subjects: 786
Study 32040183 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP demonstration project enrollment
Number of subjects: 786
Study 35422869 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with standard antiemetics (Arm A)
Number of subjects: 42
Study 35422869 — intervention group
Group type: COMPARATOR
Intervention: Standard antiemetics only (Arm C)
Number of subjects: 42
Study 32479591 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated intervention (in-depth assessment, personalised care plans, and coordinated care)
Number of subjects: 453
Study 32479591 — intervention group
Group type: COMPARATOR
Intervention: Control group (group education session on frailty prevention)
Number of subjects: 453
Study 35139572 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate Counting Method (CCM)
Number of subjects: 89
Study 35139572 — intervention group
Group type: COMPARATOR
Intervention: Traditional Method (TM)
Number of subjects: 89
Study 35139572 — intervention group
Group type: EXPERIMENTAL
Intervention: CCM
Number of subjects: 89
Study 35139572 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (CCM and TM)
Number of subjects: 89
Study 35139572 — intervention group
Group type: EXPERIMENTAL
Intervention: Cesarean delivery
Number of subjects: 89
Study 35612399 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 30
Study 35612399 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study 34625598 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (EXE)
Number of subjects: 159
Study 34625598 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (GLAR)
Number of subjects: 159
Study 32295524 — intervention group
Group type: EXPERIMENTAL
Intervention: Health TAPESTRY intervention
Number of subjects: 84
Study 35272982 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin qigong intervention
Number of subjects: 28
Study 35272982 — intervention group
Group type: COMPARATOR
Intervention: Active control condition (light flexibility exercise)
Number of subjects: 28
Study 32682507 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated fennel therapy
Number of subjects: 381
Study 36397122 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 sessions of posterior cingulate cortex (PCC) ISF‐NFB up‐training (n=15)
Number of subjects: 60
Study 36397122 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 sessions of concurrent PCC ISF up‐training and dorsal anterior cingulate cortex (dACC) ISF‐NFB down‐training (n=15)
Number of subjects: 60
Study 36397122 — intervention group
Group type: COMPARATOR
Intervention: 6 sessions of yoked‐sham training followed by 6 sessions genuine ISF‐NFB (n=30)
Number of subjects: 60
Study 33498640 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium meal plan (0.9 mg/kcal)
Number of subjects: 20
Study 33498640 — intervention group
Group type: COMPARATOR
Intervention: Typical sodium meal plan (2 mg/kcal)
Number of subjects: 20
Study 32285223 — intervention group
Group type: EXPERIMENTAL
Intervention: AT13148 treatment in BT474 and PC3 cells
Number of subjects: 0
Study 32285223 — intervention group
Group type: EXPERIMENTAL
Intervention: AT13148 treatment in non-tumor bearing mice
Number of subjects: 0
Study 32285223 — intervention group
Group type: EXPERIMENTAL
Intervention: AT13148 treatment in patients at doses of 160-300 mg
Number of subjects: 0
Study 34453027 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-task balance training
Number of subjects: 69
Study 34453027 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task balance training
Number of subjects: 69
Study 34453027 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 69
Study 33775927 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) targeting the bilateral dorsolateral prefrontal cortex
Number of subjects: 781
Study 33775927 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 781
Study 33775927 — intervention group
Group type: EXPERIMENTAL
Intervention: High- and low-frequency rTMS
Number of subjects: 781
Study 33775927 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 781
Study 32001397 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intensive rehabilitation management (from 7 days after injury, 7 d/wk, 4 times/d, 1 h/session) for 4 weeks
Number of subjects: 87
Study 32001397 — intervention group
Group type: COMPARATOR
Intervention: Ordinary rehabilitation (from 14 days after injury, 5 d/wk, 2 times/d, 1 h/session) for 4 weeks
Number of subjects: 87
Study 34665023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone with silicone tamponade (Group-1)
Number of subjects: 43
Study 34665023 — intervention group
Group type: COMPARATOR
Intervention: Silicone tamponade only (Group-2)
Number of subjects: 43
Study 33221117 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led intervention (6-week, six 90-minute group-based training sessions)
Number of subjects: 359
Study 33221117 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led intervention
Number of subjects: 359
Study 33221117 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 359